JJ, K., C, K., P, G., D, K., L, G., M, E., . . . H, G. (2022). Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b. Leukemia, 36(5), 1408. https://doi.org/10.1038/s41375-022-01528-x
Chicago Style (17th ed.) CitationJJ, Kiladjian, et al. "Long-term Outcomes of Polycythemia Vera Patients Treated with Ropeginterferon Alfa-2b." Leukemia 36, no. 5 (2022): 1408. https://doi.org/10.1038/s41375-022-01528-x.
MLA (9th ed.) CitationJJ, Kiladjian, et al. "Long-term Outcomes of Polycythemia Vera Patients Treated with Ropeginterferon Alfa-2b." Leukemia, vol. 36, no. 5, 2022, p. 1408, https://doi.org/10.1038/s41375-022-01528-x.
Warning: These citations may not always be 100% accurate.